Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks blood sugar in PCOS to spot diabetes risk early

NCT ID NCT07483723

First seen Mar 20, 2026 · Last updated Jun 19, 2026 · Updated 20 times

Summary

This study is looking at how blood sugar levels change throughout the day in women with polycystic ovary syndrome (PCOS). Researchers will use a continuous glucose monitor for 14 days to compare glucose patterns across four different PCOS subtypes. The goal is to better understand which women are at higher risk for insulin resistance and type 2 diabetes. 80 women with PCOS will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHRU Amiens

    RECRUITING

    Salouël, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors identify which PCOS subtypes are at highest risk for diabetes, leading to more personalized monitoring and prevention strategies.

What could go wrong

This is an observational study, not a treatment trial. It will not directly improve health, and results may not change current care for years.

Conditions

The condition(s) this trial relates to.

Insulin Resistance polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.